https://scholars.lib.ntu.edu.tw/handle/123456789/464036
標題: | Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer | 作者: | Tseng, C.-L. Wu, S.Y.-H. Wang, W.-H. Peng, C.-L. Lin, F.-H. Lin, C.-C. Young, Tai-Horng MING-JIUM SHIEH |
公開日期: | 2008 | 卷: | 29 | 期: | 20 | 起(迄)頁: | 3014-3022 | 來源出版物: | Biomaterials | 摘要: | Lung cancer is the most malignant cancer today; in order to develop an effective drug delivery system for lung cancer therapy, gelatin nanoparticles (GPs) were modified with NeutrAvidinFITC-biotinylated epidermal growth factor (EGF) to form EGF receptor (EGFR)-seeking nanoparticles (GP-Av-bEGF). Aerosol droplets of the GP-Av-bEGF were generated by using a nebulizer and were delivered to mice model of lung cancer via aerosol delivery. Analysis of the aerosol size revealed that 99% of the nanoparticles after nebulization had a mass median aerodynamic diameter (MMAD) within the suitable range (0.5-5 μm) for lower airway deposition. The safety of inhaled nanoparticles was examined by lung edema and myeloperoxidase (MPO) activity assay. There's no finding suggestive of acute lung inflammation following inhalation. The fluorescence images obtained from live mice showed that the GP-Av-bEGF could target the cancerous lungs in a more specific manner. Fluorescence analysis of the organs revealed that the GP-Av-bEGF was mainly distributed in cancerous lungs. In contrast, nanoparticle accumulation was lower in normal lungs. The histological results indicated that the fluorescent GP-Av-bEGF was colocalized with the anti-EGFR-immunostain due to EGFR binding. The results of this study revealed that GP-Av-bEGF could target to the EGFR-overexpression cancer cells in vivo and may prove to be beneficial drug carriers when administered by simple aerosol delivery for the treatment of lung cancer. ? 2008 Elsevier Ltd. All rights reserved. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/464036 | DOI: | 10.1016/j.biomaterials.2008.03.033 | SDG/關鍵字: | Aerosols; Drug delivery; Enzymes; Rats; Gelatin; Lung cancer; Nanoparticles; avidin; drug carrier; epidermal growth factor; gelatin; myeloperoxidase; nanoparticle; aerosol; animal experiment; animal model; animal tissue; article; biotinylation; controlled study; drug conjugation; drug delivery system; drug distribution; enzyme activity; fluorescence analysis; lung cancer; lung edema; male; mouse; nebulization; nonhuman; nude mouse; priority journal; scanning electron microscopy; Aerosols; Animals; Biotin; Epidermal Growth Factor; Gelatin; Lung Neoplasms; Male; Mice; Mice, Nude; Microscopy, Electron, Scanning; Nanoparticles; Tissue Distribution; Mus; Mus musculus |
顯示於: | 醫學工程學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。